共 50 条
- [42] Sonic: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to Immunomodulators and biologic therapy AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S436 - S436
- [44] Health-Related Quality of Life With Ustekinumab vs Adalimumab for Induction and Maintenance Therapy in Biologic-Naive Patients With Moderate-To-Severe Crohn's Disease: IBDQ in the SEAVUE Study AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S355 - S357
- [46] Which should come first? Surgery or biologic therapy for ileocaecal Crohn's disease in biologic naive patients JOURNAL OF CROHNS & COLITIS, 2022, 16 : I348 - I349
- [47] Which should come first? Surgery or biologic therapy for ileocaecal Crohn's disease in biologic naive patients JOURNAL OF CROHNS & COLITIS, 2022, 16 : I348 - I349
- [49] Development of Creutzfeldt-Jakob disease during infliximab and ustekinumab therapy for refractory Crohn's colitis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S22 - S23
- [50] Infliximab vs. hydrocortisone for Crohn's disease patients requiring hospitalization AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S297 - S297